基于肾藏精理论探讨维生素D与弥漫性毒性甲状腺肿的关系  

Study on the Relationship Between Vitamin D and Graves Based on the Theory of Kidney Storing Essence

作　　者：符芳 李双蕾[1,2] 吴淑媛 洪晓华 FU Fang;LI Shuanglei;WU Shuyuan;HONG Xiaohua(Guangxi University of Chinese Medicine,Nanning Guangxi China 530023;The First Affiliated Hospital of Guangxi University of Chinese Medicine,Nanning Guangxi China 530022)

机构地区：[1]广西中医药大学,广西南宁530023 [2]广西中医药大学第一附属医院,广西南宁530022

出　　处：《中医学报》2020年第7期1404-1407,共4页Acta Chinese Medicine

基　　金：国家自然科学地区基金课题项目(81860784);广西名老中医民族医学传承工作室建设项目{桂卫中[2014]9号}。

摘　　要：肾精属于先天之精,参与人体的生长发育,肾不藏精导致肾精不足而影响人体的生长发育。弥漫性毒性甲状腺肿(Graves,GD)的发病机制与维生素D(Vitamin D,VD)在人体内的作用机制亦存在相关性。GD患者存在VD水平低下的现象,VD水平低下可导致GD发病率增高或者治疗、转归及预后相对较差。VD为肾精的物质基础,为肾所藏之精,可以促进人体生长发育。因此,通过补充VD或者应用补肾药物可以提高GD的治愈率及缩短疗程。Kidney essence belongs to the innate essence,which participates in the growth and development of human body.The lack of kidney essence leads to the deficiency of kidney essence and affects the growth and development of human body.The pathogenesis of Graves(GD)is also related to the mechanism of Vitamin D(VD)in human body.GD patients have low VD level.Low VD level can lead to higher incidence rate of GD or poor prognosis.VD is the material basis of kidney essence,which can promote the growth and development of human body.Therefore,VD or kidney tonic drugs can improve the cure rate and shorten the course of treatment of GD.

关 键 词：弥漫性毒性甲状腺肿 维生素D 肾藏精 瘿病 

分 类 号：R265[医药卫生—中医外科学]